New Study Results from CHORD Trial: Significant Hearing Improvements in Almost All Children with Severe Genetic Hearing Loss Using DB OTO Technology

marketinsights05 mins

Regeneron Pharmaceuticals Announces Encouraging Results from CHORD Trial of DB-OTO Gene Therapy for Genetic Hearing Loss Regeneron Pharmaceuticals, a leading biotechnology company, recently released updated data from the Phase 1/2 CHORD (Combining Hearing Restoration and Otoferlin Delivery) trial. This trial involves the investigational gene therapy DB-OTO, designed to treat profound genetic hearing loss caused by…

Read More

Levi and Korsinsky: A Reminder to Intellia Therapeutics Investors About the Upcoming Class Action Lawsuit

marketsgonewild05 mins

Understanding Your Options After Suffering a Loss from Intellia Therapeutics, Inc. (NASDAQ: NTLA) If you’ve recently experienced a financial loss as a result of investing in Intellia Therapeutics, Inc. (NASDAQ: NTLA), you may be wondering what steps you can take to potentially recover your losses. In this blog post, we’ll provide you with important information…

Read More

Levi and Korsinsky: A Friendly Reminder to Alarum Technologies Ltd. Investors: Tick Tock, Your Time to Act May Be Running Out!

marketinsights07 mins

Suffered a Loss on Alarum Technologies Ltd. (ALAR) Investment? Here’s What You Need to Know If you’ve recently experienced a financial loss as a result of investing in Alarum Technologies Ltd. (ALAR) and are considering taking legal action, you’re not alone. The securities laws provide a means for investors to recover their losses in certain…

Read More

Get Ready to Energize with Performance Contractors: Joining Forces with CEH Renewable Energy and Technology Alliance for a Liquid Green Hydrogen Future!

marketinsider04 mins

Welcome to the Exciting World of Performance Contractors, Inc. and Bair Energy’s Renewable Energy Alliance! The Alliance Unveiled It is with great pleasure that we announce the recent partnership between Performance Contractors, Inc. (Performance) and Bair Energy’s (BE) Renewable Energy and Technology Alliance. This groundbreaking alliance recognizes Performance’s strengths in mechanical cryogenic equipment, large-scale piping…

Read More

Friedman Industries Announces Cash Dividend: Details and Implications for Shareholders

marketnews04 mins

Friedman Industries Announces 213th Consecutive Quarterly Cash Dividend On March 19, 2025, the Board of Directors of Friedman Industries, Incorporated (FRD) made an important announcement. The company, based in LONGVIEW, Texas, declared a cash dividend of $0.04 per share on its Common Stock. This dividend is a testament to the company’s financial stability and commitment…

Read More

TransMedics Group (TMDX) Sued for Alleged Fraud and Safety Lapses: A Charming but Troubling Turn for the Medical Device Company – Hagens Berman Leads Class Action Lawsuit

newsmaker05 mins

A Controversial Turn for TransMedics Group: Allegations of Fraud and Concealed Safety Issues In the bustling heart of San Francisco, where innovation and progress are the norm, a storm has brewed that threatens to shake the foundations of TransMedics Group, Inc. (TMDX), a medical technology trailblazer specializing in organ transplant therapy. On March 24, 2025,…

Read More

Dogwood Therapeutics Regains Compliance with Nasdaq: A Heartfelt Update on the Company’s Journey Back to Growth

marketinsights04 mins

Dogwood Therapeutics Regains Compliance with Nasdaq Listing Rule Atlanta, GA – April 3, 2025 – Dogwood Therapeutics, Inc. (Nasdaq: DWTX), a biopharmaceutical company dedicated to developing new medicines to treat pain and fatigue-related disorders, announced today that it believes it has regained compliance with the minimum stockholders’ equity requirement as outlined in Nasdaq Listing Rule…

Read More